Mark Dunphy
speaker
72 appearances
1 recordings
1 series
first heard Sep 2025
last heard 30 Sep
Mark Dunphy’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
We manufacture for life-saving therapies, including vaccines, monoclonal antibodies, and gene therapies.
But you're right, we also manufacture medical devices, vaccines,
And within the medical device, the filtration system, it removes harmful bacteria and viruses from medications.
And yet one application of a medical device is an epidural.
You're dead right.
Yes.
Correct.
Yeah.
So it would go and the filter would go before the actual syringe.
It's one of many applications of one of our membrane or one of our devices where our membrane is used.
And that product is manufactured in a carry tool facility.
Correct.
So the investment in Balarni, it's about 150 million euros.
So it's part of our overall 450 million investment in Cork, which is the largest ever.
Single site investment with Merck Life Science.
So it enables the expansion of capacity for critical filtration technologies and it'll supply the entire biopharma industry, especially those that support production of the monoclonal antibodies, as I said already, vaccines and some of the advanced therapies.
But to your point, for sure, yeah, it's 100% powered by renewable electricity.
climate neutrality built into our operations through renewable energy, heat recovery and advanced water recycling.
We're proud to say it's Merck's first manufacturing site designed for climate neutrality.
Sure.
Showing 21–40 of 72 · page 2 of 4
← Previous
Next →